Table 2.
MDACC Stage | Evaluation cohort n=1, 202 | Treatment subgroup n=733 |
---|---|---|
0 - no visible edema, heaviness" | 9 (1%) | 2 (1%) |
1a - soft visible edema, no pitting | 336 (28%) | 178 (24%) |
1b – reversible, pitting edema | 746 (62%) | 487 (66%) |
2 – non reversible, firm, pitting | 111 (9%) | 66 (9%) |
HNL Site (not mutually exclusive) | ||
Neck | 1,079 (90%) | 669 (91%) |
Submental | 1,067 (89%) | 706 (96%) |
Facial | 638 (53%) | 383 (53%) |
Intra-oral | 156 (18%) | 100 (14%) |
Associated Complaints | ||
Cosmetic | 999 (83%) | 614 (84%) |
Discomfort | 764 (64%) | 478 (65%) |
Functional | 446 (37%) | 287 (39%) |
Swallowing | 303(25%) | 192 (26%) |
Breathing | 174 (15%) | 113 (16%) |
Speaking | 128 (11%) | 76 (10%) |
Vision | 27 (2%) | 14 (2%) |